Introduction
============

GI disorders have been more common among the diabetic subjects as the incidence of diabetes has increased. The entire GI tract can be affected by diabetes and common GI complications include abnormal GI (esophageal, gastric, or enteric) motility, nonalcoholic fatty liver disease, and glycogenic hepatitis.[@b1-jnm-25-387] Among GI complications, a delay in gastric emptying (GE) occurs in subjects with longstanding type 1 or type 2 diabetes.[@b2-jnm-25-387] Several cross-sectional studies showed that 30--50% of long-standing diabetic outpatients had delayed GE, which may cause chronic upper gastrointestinal (UGI) symptoms such as nausea, vomiting, postprandial fullness, and early satiety.[@b3-jnm-25-387]--[@b5-jnm-25-387]

The pathophysiology of a delay in GE is incompletely understood and considered as multifactorial: impaired glycemic control, loss of the interstitial cells of Cajal and autonomic neuropathy. Diabetic autonomic neuropathy include extrinsic vagal neuropathy and reduction of intrinsic inhibitory neurons that mediate gastric accommodation or contractions,[@b2-jnm-25-387],[@b6-jnm-25-387] which may be overlapped with cardiac autonomic neuropathy as one of the risk factors for cardiovascular diseases in diabetes.[@b7-jnm-25-387] Although several cross-sectional studies reported that diabetic subjects with delayed GE had more frequently hypertension and coronary artery disease than those without delayed GE,[@b8-jnm-25-387],[@b9-jnm-25-387] there is limited data on the relationships between the degree of a delay in GE and the incidence of cardiovascular events following GE study in subjects with diabetes to date.

In this study, we aim to investigate associations between GE time and the major cardiovascular events (coronary heart diseases and ischemic stroke) after GE study in diabetic subjects with UGI symptoms.

Materials and Methods
=====================

We designed this retrospective observational study to investigate the incidence of cardiovascular disease in diabetic subjects with UGI symptoms after GE study. The present study was conducted in accordance with the Ethical Guidelines of the Declaration of Helsinki. This study was approved by the Institutional Review Board of Chonnam National University Hospital (No. CNUH-2018-245). We had requested the list of subjects who underwent GE study between January 2001 and December 2017 to the department of medical records in our center. We found 259 subjects who had undergone GE study for the evaluation of chronic UGI symptoms between April 2004 and December 2017. Among them, there were 165 subjects with diabetes. Inclusion criteria were (1) subjects with diabetes ≥ 18 years old; (2) the absence of known gastric obstruction on endoscopy or UGI series. We performed gastric emptying study (GES) using ^99m^Technetium sulfur colloid radiolabeled boiled eggs.[@b10-jnm-25-387] All subjects were obtained in the anterior and posterior projection immediately and at 5, 10, 20, 30, 45, 60, 90, and 120 minutes after meal ingestion while the subjects were standing. Scintigraphic images were obtained with a large field of view of the gamma camera using a low energy all-purpose collimator with a 20% energy window setting centered at 140 keV. Patients were allowed to sit in a chair between the standing images acquisitions. We excluded patients with "rapid GE" which was defined as \< 30% retention at 1 hour or previous gastric surgery. We estimated GE half-time (GE T~½~) using linear interpolation using all the scan times over the image sequence. GE was divided into 3 grades according to time. "Normal GE" was defined as GE T~½~ \<72 minutes, "mild delayed GE" as GE T~½~ ≥ 72 to \< 144 minutes, and "marked delayed GE" as GE T~½~ \> 144 minutes.[@b11-jnm-25-387],[@b12-jnm-25-387]

We collected demographic data for enrolled patients when they underwent GES. Definitions of comorbid conditions were as follows; hypertension (≥ 140/90 mmHg or antihypertensive drugs), dyslipidemia (serum total cholesterol level ≥ 6.22 mmol/L, serum low-density lipoprotein cholesterol level ≥ 4.14 mmol/L, serum triglycerides level ≥ 2.27 mmol/L, serum high-density lipoprotein cholesterol level \< 1.04 mmol/L or taking the lipid-regulating drugs),[@b13-jnm-25-387] chronic kidney disease (serum creatinine level \> 133 μmol/L in men and serum creatinine level \> 106 μmol/l in women) in study subjects. We collected the data on carotid intima-media thickness (IMT) and ankle-brachial pressure index (ABPI). Carotid IMT was measured on the far wall of right and left common carotid artery at a site approximately 10 mm proximal to the carotid bulb, using IMT measurement software Intimascope (Media Cross Co. Ltd, Tokyo, Japan). We used the mean values of the right and left carotid IMT. Plaque was defined when the vessel wall thickness was \> 1.5 mm or when protrusion into the lumen was 50% thicker than the surrounding area. ABPI was calculated automatically in the supine position using the VaSeraTM VS-1000 (Fukuda Densi, Tokyo, Japan) with cuffs around both arms and ankles. The lowest value of the left and right ABPI was used for analysis. We defined "previous cardiovascular diseases," which were assessed by reports of cardiologists, neurologists, and diabetologists who evaluated the patients based on clinical symptoms and objective examinations according to international guidelines.

The outcomes for the present study were the occurrence of coronary heart disease and ischemic stroke after GES. Coronary heart disease was defined on the basis of myocardial infarction, angina pectoris or ischemic heart disease, coronary artery angioplasty, or new pathological findings coded using Minnesota codes 1.1 to 3, 4.1 to 4, and 5.1 to 3 in the resting electrocardiogram.[@b14-jnm-25-387] A diagnosis of ischemic stroke was based on medical records, if pathological findings such as ischemic stroke on computed tomography or an area of low signal intensity measuring at least 3 mm on T1-weighted images and a hyper-intense lesion on T2-weighted images on magnetic resonance imaging of the brain had been documented.[@b15-jnm-25-387] Cardiovascular events were considered a composite of coronary heart disease and ischemic stroke. Data on the incidence of cardiovascular events after GES were collected from electronic medical records until Aug 2018.

Statistical Methods
-------------------

Data was expressed as the mean ± SD, unless otherwise stated. Variables with a skewed distribution were log-transformed prior to analysis, and the data were represented as geometric mean (95% CI). Continuous variables were analyzed using the Mann-Whitney U test or Student's *t* test. Pearson' Chi-squared test was used to compare the incidence of cardiovascular events among each group. Multivariate logistic regression model was used to assess whether clinical variables at diagnosis were associated with the risk of incidence of cardiovascular events after GE studies. Statistical analysis was performed using SPSS software version 20.0 (IBM Corp, Armonk, NY, USA). A *P*-value of less than 0.05 considered statistically significant.

Results
=======

There were 259 subjects who underwent GE studies for the evaluation of chronic UGI symptoms between April 2004 and December 2017. Among them, there were 165 diabetic subjects. We excluded 37 subjects with rapid GE and 6 subjects who had undergone gastric surgery. Finally, 122 subjects were included in this study ([Figure](#f1-jnm-25-387){ref-type="fig"}). The mean age of enrolled patients was 64.0 ± 17.4 years. There were 86 women (70.5%) and 104 (85.2%) with type 2 diabetes. Eight subjects had a history of coronary heart disease, 7 subjects had a history of ischemic stroke, and 3 subjects had both histories of coronary heart disease and ischemic stroke.

The most common presenting symptoms were nausea (56.6%) and vomiting (43.4%). There were 52 subjects (42.6%) with "normal GE" and 70 subjects (57.4%) with "delayed GE." Among subjects with delayed GE, 20 patients had "marked delayed GE."

[Table 1](#t1-jnm-25-387){ref-type="table"} demonstrates the baseline demographic factors and clinical characteristics in the enrolled subjects. There were 48 (92.3%) subjects with type 2 diabetes in "normal GE," 42 (84.0%) subjects with type 2 diabetes in "mild delayed GE," and 14 (70.0%) subjects with type 2 diabetes in marked "delayed GE" (*P* = 0.054).

Among subjects with marked delayed GE, 60.0% subjects had vomiting, while 50.0% subjects with normal GE and 30.0% subjects with mild GE had vomiting (*P* = 0.033). Among 122 subjects, 76 subjects had ABPI measurements and 42 had carotid IMT measurements. There was no significant differences in ABPI according to baseline characteristics (normal GE \[n = 33\], 1.09 ± 0.14; mild delayed GE \[n = 29\], 1.04 ± 0.14; marked delayed GE \[n = 14\], 1.11 ± 0.10 mm; *P* = 0.207). In addition, there were no significant differences in carotid IMT and the presence of plaque according to baseline characteristics (normal GE, 0.86 ± 0.32 mm; mild delayed GE, 0.86 ± 0.29 mm; marked delayed GE, 0.82 ± 0.28 mm; *P* = 0.938 and normal GE, 5/20 (25.0%); mild delayed GE, 3/14 (21.4%); marked delayed GE 3/8 (37.5%); *P* = 0.702, respectively).

Incidence of Cardiovascular Events in Diabetic Patients With Upper Gastrointestinal Symptoms
--------------------------------------------------------------------------------------------

There were 18 subjects with cardiovascular events during follow-up period \[median (quartile), 207 weeks (range, 86--390)\]. Ischemic stroke occurred in 8 subjects and coronary heart disease occurred in 10 subjects.

From the medical records of 122 subjects, we identified 9 subjects (3 with normal GE, 4 with mild delayed GE and 2 with marked delayed GE) who died due to complications of ischemic stroke (n = 2), uncontrolled infection (n = 4), malignancy (n = 2), and postoperative complication (n = 1).

Baseline Demographics and Clinical Factors Between Subjects Without Cardiovascular Events and Subjects With Cardiovascular Events After Gastric Emptying Study
--------------------------------------------------------------------------------------------------------------------------------------------------------------

There was no significant difference in baseline demographics between subjects without cardiovascular events and subjects with cardiovascular events ([Table 2](#t2-jnm-25-387){ref-type="table"}). However, there was a significant difference in previous history of cardiovascular diseases between the 2 groups (*P* = 0.006). There was a significant difference in degree of GE T~½~ between the 2 groups (*P* = 0.015). In addition, subjects with cardiovascular events had longer GE T~½~ than those without cardiovascular events after GE study (*P* = 0.008, [Table 2](#t2-jnm-25-387){ref-type="table"}).

Among subjects with cardiovascular events after GE study, subjects with new-onset cardiovascular events (geometric mean \[95% CI\], 227.9 min \[113.1--459.4\]) had longer T~½~ GE than patients with both previous history of cardiovascular disease and cardiovascular events during follow-up period (63.4 min \[range, 26.4--152.8\], *P* = 0.044).

Univariate and Multivariate Analysis of Risk Factors for Incidence of Cardiovascular Events After Gastric Emptying Study
------------------------------------------------------------------------------------------------------------------------

In univariate analysis, GE T~½~ was significantly associated with incidence of cardiovascular events (crude odds ratio \[OR\], 1.74; 95% CI, 1.12--2.69; *P* = 0.014). In a multivariate model adjusted by baseline characteristics and comorbidities, GE T~½~ and previous history of cardiovascular disease were significantly associated with incidence of cardiovascular events (adjusted odds ratio \[aOR\], 1.94; 95% CI, 1.21--3.12; *P* = 0.006 and aOR, 6.98; 95% CI, 1.98--24.60; *P* = 0.003, respectively) ([Table 3](#t3-jnm-25-387){ref-type="table"}).

We further investigated the relationship between GE T~½~ and cardiovascular events in 104 subjects without previous history of cardiovascular disease. Univariate analysis showed that GE T~½~ was significantly associated with incidence of new-onset cardiovascular events (cOR, 3.33; 95% CI, 1.65--6.75; *P* = 0.001). In a multivariate model adjusted by baseline characteristics and comorbidities (in [Table 3](#t3-jnm-25-387){ref-type="table"}), T~½~ GE was significantly associated with incidence of new-onset cardiovascular events (aOR, 2.99; 95% CI, 1.49--6.01; *P* = 0.002).

Discussion
==========

In this study, cardiovascular events occurred in 18 subjects during 207 weeks of follow-up period. Ischemic stroke occurred in 8 subjects and coronary heart disease occurred in 10 subjects. In addition, GE time was independently associated with incidence of cardiovascular events after adjustment for comorbidities.

The subjects with long standing diabetes mellitus may have variable UGI symptoms including nausea, vomiting, early satiety, or bloating. Several studies showed the poor relationship with UGI symptoms and GE.[@b4-jnm-25-387],[@b16-jnm-25-387],[@b17-jnm-25-387] Furthermore, symptoms of delayed GE overlap with those of rapid GE or functional dyspepsia.[@b18-jnm-25-387] Previous studies showed that 36% of diabetic subjects had delayed GE and 22% had rapid GE.[@b16-jnm-25-387],[@b19-jnm-25-387] In our study, 23.2% (37/159) diabetic subjects with chronic UGI symptoms had rapid GE, which was similar to the findings of previous studies.

GE disorders impact on substantial morbidity and quality of life in subjects with diabetes.[@b8-jnm-25-387],[@b20-jnm-25-387] Gastroparesis, defined as delayed GE in the absence of mechanical obstruction, leads to burden of health-care costs through frequent doctor visits, hospitalization and emergency room visits.[@b8-jnm-25-387],[@b21-jnm-25-387] In addition, Jung et al demonstrated that overall survival in subjects with gastroparesis was significantly lower than that of the general population, while there were inconsistent results in regards to mortality in patients with gastroparesis.[@b22-jnm-25-387],[@b23-jnm-25-387] Nevertheless, in both studies, coincident and major cause of death was cardiovascular disease, which is the most prevalent cause of morbidity and mortality in diabetic subjects.[@b24-jnm-25-387] However, the relationship between GE time and incident cardiovascular disease in subjects with diabetes is unclear to date. Previously, Camurça et al[@b25-jnm-25-387] reported that GE might be related to vascular dynamic change in animal models. Hyett et al[@b8-jnm-25-387] suggested a correlation between diabetic gastroparesis and vascular complications including hypertension, coronary artery disease, and retinopathy. Kotani et al also showed that the GE T~½~ correlated positively with IMT of the carotid bulb and negatively with ankle brachial pressure index, which are risk indicators for future vascular disorders.[@b26-jnm-25-387] In addition, the association of gastric motor disorders with diabetic autonomic neuropathy has been proposed.[@b27-jnm-25-387] Another study showed that the type 1 diabetic subjects with cardiac autonomic neuropathy had more delayed GE than those without cardiac autonomic neuropathy.[@b28-jnm-25-387] In our study, subjects with marked delayed GE had an increased incidence of cardiovascular events. Furthermore, in multivariate analysis, GE time was significantly associated with incidence of cardiovascular events after adjustment for comorbidities. In subgroup analysis, a significant association between GE and new-onset cardiovascular events was observed in subjects without previous history of cardiovascular disease. Therefore, although it is insufficient to draw causality between GE and cardiovascular events due to retrospective observation study and small number of sample size, our findings might give important information on the association between GE and cardiovascular events in Asian diabetic subjects with chronic UGI symptoms. However, we need to perform large scale and well-designed cohort studies in the future.

In conclusion, a delay in GE was associated with incidence of cardiovascular events in diabetic subjects with chronic UGI symptoms. Even though conservative management is recommended, this study may warrant a more careful cardiovascular assessment with a high index of suspicion for possible events in management of diabetic subjects with a delay in GE.

**Financial support:** This research was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (2018R1C1B5043483) and the Chonnam National University Hospital Research Institute of Clinical Medicine (CRI 18091-3).

**Conflicts of interest:** None.

**Author contributions:** Hyung-Min Park: analysis of electronic medical records and identification of patients for analysis; Jin Ook Chung: study concept and design, drafting and finalizing the manuscript; Seon-Young Park: study concept and design, analysis and interpretation of data, drafting and finalizing the manuscript, and study supervision; and Dong Hyuk Cho, Chang-Hwan Park, Hyun-Soo Kim, Dong Jin Chung, Sung-Kyu Choi, Jong-Sun Rew, and Min Young Chung: patient recruitment and care.
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###### 

Baseline Demographics and Clinical Factors in 122 Subjects With Diabetes

  Variables                          Subjects with normal GE (n = 52)   Subjects with mild delayed GE (n = 50)   Subjects with marked delayed GE (n = 20)   *P*-value
  ---------------------------------- ---------------------------------- ---------------------------------------- ------------------------------------------ -----------
  Type 2 Diabetes                    48 (92.3)                          42 (84.0)                                14 (70.0)                                  0.054
  Duration of diabetes (yr)          8.2 (6.6--10.1)                    10.5 (8.5--12.9)                         9.4 (6.7--13.2)                            0.267
  Female                             37 (71.2)                          35 (70.0)                                14 (70.0)                                  0.990
  Age (yr)                           62.1 ± 15.8                        60.6 ± 18.2                              52.4 ± 18.6                                0.098
  BMI (kg/m^2^)                      23.2 ± 4.1                         23.2 ± 3.7                               22.8 ± 4.5                                 0.920
  Smoking                            8 (15.4)                           6 (12.0)                                 2 (10.0)                                   0.795
  Glycated hemoglobin (%)            8.2 ± 1.5                          8.6 ± 2.4                                9.0 ± 2.2                                  0.293
  Comorbid diseases                                                                                                                                         
   Hypertension                      27 (51.9)                          21 (42.0)                                11 (55.0)                                  0.490
   Previous cardiovascular disease   9 (17.3)                           8 (16.0)                                 1 (5.0)                                    0.387
   Chronic kidney disease            16 (30.8)                          18 (36.0)                                6 (30.0)                                   0.818
   Dyslipidemia                      40 (76.9)                          31 (62.0)                                16 (80.0)                                  0.161
  Upper gastrointestinal symptoms                                                                                                                           
   Nausea                            30 (57.7)                          28 (56.0)                                11 (55.0)                                  0.974
   Vomiting                          26 (50.0)                          15 (30.0)                                12 (60.0)                                  0.033
   Bloating                          1 (1.9)                            1 (2.0)                                  0 (0.0)                                    0.640
   Epigastric discomfort             13 (25.0)                          11 (22.0)                                6 (30.0)                                   0.778

BMI, body mass index; GE, gastric emptying.

"Normal GE" was defined as GE time \< 72 minutes, "mild delayed GE" as ≥ 72 to \< 144 minutes and "marked delayed GE" as \> 144 minutes.

Values are given as the mean ± SD, geometric mean (95% CI), or n (%).

###### 

Baseline Demographics and Clinical Factors Between Subjects Without Cardiovascular Events and Subjects With Cardiovascular Events After Gastric Emptying Study

  Variables                          Subjects without cardiovascular events (n = 104)   Subjects with cardiovascular events (n = 18)   *P*-value
  ---------------------------------- -------------------------------------------------- ---------------------------------------------- -----------
  Type 2 diabetes                    88 (84.6)                                          16 (88.9)                                      0.999
  Duration of diabetes (yr)          9.0 (7.7--10.4)                                    11.2 (7.8--16.0)                               0.261
  Female                             76 (73.1)                                          10 (55.6)                                      0.132
  Age (yr)                           59.2 ± 18.1                                        64.0 ± 12.8                                    0.178
  BMI (kg/m^2^)                      23.2 ± 4.1                                         22.5 ± 3.5                                     0.496
  Smoking                            11 (10.6)                                          5 (27.8)                                       0.061
  Glycated hemoglobin (%)            8.5 ± 2.1                                          8.6 ± 1.9                                      0.831
  Comorbid diseases                                                                                                                    
   Hypertension                      49 (47.1)                                          10 (55.6)                                      0.508
   Previous cardiovascular disease   11 (10.6)                                          7 (38.9)                                       0.006
   Chronic kidney disease            25 (24.0)                                          6 (33.3)                                       0.393
   Dyslipidemia                      76 (73.1)                                          11 (61.1)                                      0.300
  Degree of GE                                                                                                                         0.015
   Normal                            45 (43.3)                                          7 (38.9)                                       
   Mild                              46 (44.2)                                          4 (22.2)                                       
   Marked                            13 (12.5)                                          7 (38.9)                                       
  GE T~½~ (min)                      83.4 (72.3--96.2)                                  138.7 (98.2--195.4)                            0.008

BMI, body mass index; GE, gastric emptying; GE T~½~, gastric emptying half-time.

Values are given as the mean ± SD, geometric mean (95% CI), or n (%).

###### 

Clinical Factors for Cardiovascular Events in Diabetic Subjects With Upper Gastrointestinal Symptoms

  Variables                          Unadjusted           Model 1   Model 2                                          
  ---------------------------------- -------------------- --------- ------------------- ------- -------------------- -------
  Age (yr)                           1.02 (0.99--1.05)    0.280                                                      
  Male                               2.17 (0.78--6.06)    0.138                                                      
  BMI (kg/m^2^)                      0.95 (0.83--1.09)    0.493                                                      
  Subtypes of diabetes                                    0.639                                                      
   Type 1                            1                                                                               
   Type 2                            1.46 (0.31--6.95)                                                               
  Duration of diabetes (yr)          1.03 (0.97--1.09)    0.396                                                      
  Glycated hemoglobin (%)            1.03 (0.81--1.31)    0.830                                                      
  Smoking                            3.25 (0.97--10.86)   0.055                                                      
  Comorbid diseases                                                                                                  
   Hypertension                      1.40 (0.51--3.84)    0.509                                                      
   Previous cardiovascular disease   5.38 (1.73--16.74)   0.004                                 6.98 (1.98--24.60)   0.003
   Chronic kidney disease            2.36 (0.85--6.50)    0.098                                                      
   Dyslipidemia                      1.73 (0.61--4.90)    0.304                                                      
   Gastric GE time                                                                                                   
    Ln (GE T~½~), + 1 SD             1.74 (1.12--2.69)    0.014     1.63 (1.05--2.53)   0.029   1.94 (1.21--3.12)    0.006

cOR, crude odds ratio; aOR, adjusted odds ratio; CI, confidence interval; BMI, body mass index; GE T~½~, gastric emptying half-time; Ln, natural logarithm; SD, standard deviation.

Model 1, adjusted by age, gender, BMI, and habit of smoking.

Model 2, adjusted by age, gender, BMI, habit of smoking, duration of diabetes, glycated hemoglobin, hypertension, chronic kidney disease, dyslipidemia, and previous history of cardiovascular disease.

Odds ratio was calculated for any 1 SD increase in Ln (GE T~½~).
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